Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology
Free Medical Books

  Lung Cancer

  Free Subscription


Articles published in Lung Cancer

Retrieve available abstracts of 299 articles:
HTML format
Text format



Single Articles


    January 2012
  1. DI MAIO M , Signoriello S, Morabito A, Rossi A, et al
    Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available



  2. ITO M , Yamashita Y, Miyata Y, Ohara M, et al
    Prognostic impact of the primary tumor location based on the hilar structures in non-small cell lung cancer with mediastinal lymph node metastasis.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available



  3. BRUGGER W , Thomas M
    EGFR-TKI resistant non-small cell lung cancer (NSCLC): New developments and implications for future treatment.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available



  4. VANSTEENKISTE J , Glaspy J, Henry D, Ludwig H, et al
    Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: Study-level and patient-level meta-analyses.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available



  5. GRIDELLI C , de Marinis F, Di Maio M, Ardizzoni A, et al
    Maintenance treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available



  6. SANTONICO M , Lucantoni G, Pennazza G, Capuano R, et al
    In situ detection of lung cancer volatile fingerprints using bronchoscopic air-sampling.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available



  7. XUE X , Sun DF, Sun CC, Liu HP, et al
    Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: In vitro and in vivo studies.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available



  8. SATOH H , Saito R, Hisata S, Shiihara J, et al
    An ectopic ACTH-producing small cell lung carcinoma associated with enhanced corticosteroid biosynthesis in the peritumoral areas of adrenal metastasis.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available



  9. NIHO S , Kunitoh H, Nokihara H, Horai T, et al
    Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available



  10. ISHIKAWA M , Miyahara R, Sonobe M, Horiuchi M, et al
    Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available



  11. YIRMIBESOGLU E , Higginson DS, Fayda M, Rivera MP, et al
    Challenges scoring radiation pneumonitis in patients irradiated for lung cancer.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available



  12. HEUVERS ME , Aerts JG, Hegmans JP, Veltman JD, et al
    History of tuberculosis as an independent prognostic factor for lung cancer survival.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available



  13. CROMWELL I , van der Hoek K, Malfair Taylor SC, Melosky B, et al
    Erlotinib or best supportive care for third-line treatment of advanced non-small-cell lung cancer: A real-world cost-effectiveness analysis.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available



  14. GAO G , Chu H, Zhao L, Gui T, et al
    A meta-analysis of paclitaxel-based chemotherapies administered once every week compared with once every 3 weeks first-line treatment of advanced non-small-cell lung cancer.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available



    December 2011
  15. O'FLAHERTY JD , Gray S, O'Leary JJ, Blackhall FH, et al
    Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  16. LIN M , Ambati C
    The management impact of clinically significant incidental lesions detected on staging FDG PET-CT in patients with non-small cell lung cancer (NSCLC): An analysis of 649 cases.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  17. ROUQUETTE I , Lauwers-Cances V, Allera C, Brouchet L, et al
    Characteristics of lung cancer in women: Importance of hormonal and growth factors.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  18. MASSUTI B , Cobo M, Camps C, Domine M, et al
    Trabectedin in patients with advanced non-small-cell lung cancer (NSCLC) with XPG and/or ERCC1 overexpression and BRCA1 underexpression and pretreated with platinum.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  19. BAEK JH , Kim H, Ahn JJ, Jegal Y, et al
    Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  20. ZHAO R , Yan Q, Lv J, Huang H, et al
    CHD5, a tumor suppressor that is epigenetically silenced in lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  21. PARK JH , Kim YJ, Lee JO, Lee KW, et al
    Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  22. BESSE B , Planchard D, Veillard AS, Taillade L, et al
    Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  23. TROBEC K , Knez L, Mesko Brguljan P, Cufer T, et al
    Estimation of renal function in lung cancer patients.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  24. STOVOLD R , Blackhall F, Meredith S, Hou J, et al
    Biomarkers for small cell lung cancer: Neuroendocrine, epithelial and circulating tumour cells.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  25. MARAMOTTI S , Paci M, Micciche F, Ciarrocchi A, et al
    Soluble epidermal growth factor receptor isoforms in non-small cell lung cancer tissue and in blood.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  26. DAHABREH IJ , Trikalinos TA, Paulus JK
    Parity and risk of lung cancer in women: Systematic review and meta-analysis of epidemiological studies.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  27. GRUNNET M , Sorensen JB
    Carcinoembryonic antigen (CEA) as tumor marker in lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  28. JUST PA , Cazes A, Audebourg A, Cessot A, et al
    Histologic subtypes, immunohistochemistry, FISH or molecular screening for the accurate diagnosis of ALK-rearrangement in lung cancer: A comprehensive study of Caucasian non-smokers.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  29. NUIJTEN MJ , de Castro Carpeno J, Chouaid C, Vergnenegre A, et al
    A cross-market cost comparison of erlotinib versus pemetrexed for first-line maintenance treatment of patients with locally advanced or metastatic non-small-cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  30. TIAN Y , Zhang J, Yan S, Qiu L, et al
    FATS expression is associated with cisplatin sensitivity in non small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  31. SUDA K , Tomizawa K, Osada H, Maehara Y, et al
    Conversion from the "oncogene addiction" to "drug addiction" by intensive inhibition of the EGFR and MET in lung cancer with activating EGFR mutation.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  32. CHEN M , Tse LA, Au RK, Yu IT, et al
    Mesothelioma and lung cancer mortality: A historical cohort study among asbestosis workers in Hong Kong.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  33. PAIK JH , Choi CM, Kim H, Jang SJ, et al
    Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer A proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  34. COWARD JI , Nathavitharana R, Popat S
    True hypoglycaemia secondary to treatment with granulocyte colony stimulating factor (G-CSF) in a diabetic patient with non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  35. RAZ G , Allen KE, Kingsley C, Cherni I, et al
    Hedgehog signaling pathway molecules and ALDH1A1 expression in early-stage non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  36. MOUSAVI SM , Sundquist K, Hemminki K
    Risk of lung cancer by histology among immigrants to Sweden.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  37. TREAT J , Scagliotti GV, Peng G, Monberg MJ, et al
    Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): A combined analysis of three phase 3 trials.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  38. LUO J , Chen YJ, Chang LJ
    Fasting blood glucose level and prognosis in non-small cell lung cancer (NSCLC) patients.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  39. LARA-GUERRA H , Chung CT, Schwock J, Pintilie M, et al
    Histopathological and immunohistochemical features associated with clinical response to neoadjuvant gefitinib therapy in early stage non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  40. JONES LW , Hornsby WE, Goetzinger A, Forbes LM, et al
    Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  41. VON BOEHMER L , Draenert A, Jungraithmayr W, Inci I, et al
    Immunosuppression and lung cancer of donor origin after bilateral lung transplantation.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  42. FERKETICH AK , Otterson GA, King M, Hall N, et al
    A pilot test of a combined tobacco dependence treatment and lung cancer screening program.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  43. MORRA L , Rechsteiner M, Casagrande S, von Teichman A, et al
    Characterization of periostin isoform pattern in non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  44. JEON HS , Lee SY, Lee EJ, Yun SC, et al
    Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  45. RIVERA C , Jougon J, Dahan M, Falcoz PE, et al
    Are postoperative consequences of neoadjuvant chemotherapy for non-small cell lung cancer more severe in elderly patients?
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  46. NAKASHIMA N , Liu D, Huang CL, Ueno M, et al
    Wnt3 gene expression promotes tumor progression in non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  47. VAN DER AALST CM , de Koning HJ, van den Bergh KA, Willemsen MC, et al
    The effectiveness of a computer-tailored smoking cessation intervention for participants in lung cancer screening: A randomised controlled trial.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



    October 2011
  48. TANAKA N , Toyooka S, Soh J, Kubo T, et al
    Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  49. MOUSA SA , Yalcin M, Bharali DJ, Meng R, et al
    Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  50. ZAROGOULIDIS K , Eleftheriadou E, Kontakiotis T, Gerasimou G, et al
    Long acting somatostatin analogues in combination to antineoplastic agents in the treatment of small cell lung cancer patients.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  51. OP DEN KAMP CM , Langen RC, Minnaard R, Kelders MC, et al
    Pre-cachexia in patients with stages I-III non-small cell lung cancer: Systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  52. COLACO R , Sheikh H, Lorigan P, Blackhall F, et al
    Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer - Evidence from a phase II trial.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  53. MENG X , Kong FM, Yu J
    Implementation of hypoxia measurement into lung cancer therapy.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  54. VAN DER LEEST C , Smit EF, Baas J, Versteijlen RJ, et al
    SUV(max) during 18FDG-PET scanning in small cell lung cancer: Similar information as in non-small cell lung cancer?
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  55. UENO T , Tsukuda K, Toyooka S, Ando M, et al
    Strong anti-tumor effect of NVP-AUY922, a novel Hsp90 inhibitor, on non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  56. PALLIS AG , Georgoulias V
    Is there a standard regimen for first-line treatment of advanced/metastatic Non-Small-Cell Lung Cancer? What has meta-analyses contributed to today's standard of care.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  57. WU D , Xiong L, Wu S, Jiang M, et al
    TFPI-2 methylation predicts poor prognosis in non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  58. SAKR L , Roll P, Payan MJ, Liprandi A, et al
    Cytology-based treatment decision in primary lung cancer: Is it accurate enough?
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  59. PIACENTINI F , Rossi G, Casali C, Cadioli A, et al
    Primary pulmonary cancer colliding with metastatic breast carcinoma: hitherto unreported cases of cancer-to-cancer metastasis focusing on clinical implications.
    Lung Cancer. 2011;74:145-8.
    PubMed     Text format     Related articles    Abstract available



  60. YATABE Y , Borczuk AC, Powell CA
    Do all lung adenocarcinomas follow a stepwise progression?
    Lung Cancer. 2011;74:7-11.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  61. CHENG MH , Chiu HF, Ho SC, Yang CY, et al
    Statin use and the risk of female lung cancer: A population-based case-control study.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  62. GRIDELLI C , Stahel R, Besse B, Ciardiello F, et al
    Treatment decision-making for advanced non-small cell lung cancer and differences among European countries: 1st AIOT-ETOP meeting.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  63. HARO A , Yano T, Kohno M, Yoshida T, et al
    Ground-glass opacity lesions on computed tomography during postoperative surveillance for primary non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  64. TOURNOY KG , Carprieaux M, Deschepper E, van Meerbeeck JP, et al
    Are EUS-FNA and EBUS-TBNA specimens reliable for subtyping non-small cell lung cancer?
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  65. SMITH BM , Schwartzman K, Kovacina B, Taylor J, et al
    Lung cancer histologies associated with emphysema on computed tomography.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  66. FUKUMOTO K , Usami N, Okasaka T, Kawaguchi K, et al
    Late breast metastasis from resected lung cancer diagnosed by epidermal growth factor receptor gene mutation.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  67. BROCKEN P , Kiers BA, Looijen-Salamon MG, Dekhuijzen PN, et al
    Timeliness of lung cancer diagnosis and treatment in a rapid outpatient diagnostic program with combined (18)FDG-PET and contrast enhanced CT scanning.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  68. KIM HJ , Lee KY, Kim YC, Kim KS, et al
    Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  69. DE RUYSSCHER D , Nestle U, Jeraj R, Macmanus M, et al
    PET scans in radiotherapy planning of lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  70. FISCHER JR , Griesinger F, Fink T, Salm T, et al
    Docetaxel-carboplatin chemotherapy combined with cetuximab in patients with locally advanced or metastatic non small-cell lung cancer (NSCLC)-Results of the nonrandomised phase II study TaxErb.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  71. RIAZ SP , Luchtenborg M, Coupland VH, Spicer J, et al
    Trends in incidence of small cell lung cancer and all lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  72. QUOIX E , Westeel V, Zalcman G, Milleron B, et al
    Chemotherapy in elderly patients with advanced non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  73. GONG W , Zhang X, Wu J, Chen L, et al
    RRM1 expression and clinical outcome of gemcitabine-containing chemotherapy for advanced non-small-cell lung cancer: A meta-analysis.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  74. FILIPITS M , Pirker R
    Predictive markers in the adjuvant therapy of non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  75. SALAH S , Tanvetyanon T, Abbasi S
    Metastatectomy for extra-cranial extra-adrenal non-small cell lung cancer solitary metastases: Systematic review and analysis of reported cases.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  76. VARLOTTO J , Medford-Davis LN, Recht A, Flickinger J, et al
    Confirmation of the role of diabetes in the local recurrence of surgically resected non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  77. THUNNISSEN FB , Prinsen C, Hol B, Van der Drift M, et al
    Smoking history and lung carcinoma: KRAS mutation is an early hit in lung adenocarcinoma development.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  78. JACOT W , Pujol JL, Chakra M, Molinier O, et al
    Epirubicin and ifosfamide in relapsed or refractory small cell lung cancer patients.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  79. ANTUS B , Barta I
    Exhaled breath condensate pH in patients with lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  80. CORRALES-RODRIGUEZ L , Blais N
    Lung cancer associated venous thromboembolic disease: A comprehensive review.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  81. DEVRIESE LA , Bosma AJ, van de Heuvel MM, Heemsbergen W, et al
    Circulating tumor cell detection in advanced non-small cell lung cancer patients by multi-marker QPCR analysis.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  82. QUIST M , Rorth M, Langer S, Jones LW, et al
    Safety and feasibility of a combined exercise intervention for inoperable lung cancer patients undergoing chemotherapy: A pilot study.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  83. SALLOUM RG , Smith TJ, Jensen GA, Lafata JE, et al
    Factors associated with adherence to chemotherapy guidelines in patients with non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  84. NAWA T , Nakagawa T, Mizoue T, Kusano S, et al
    Long-term prognosis of patients with lung cancer detected on low-dose chest computed tomography screening.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  85. HSU HS , Lin JH, Hsu TW, Su K, et al
    Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  86. CHEN HH , Yan JJ, Chen WC, Kuo MT, et al
    Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  87. KOBAYASHI N , Usui S, Kikuchi S, Goto Y, et al
    Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  88. KIMURA H , Nakajima T, Takeuchi K, Soda M, et al
    ALK fusion gene positive lung cancer and 3 cases treated with an inhibitor for ALK kinase activity.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  89. HAN SY , Zhao MB, Zhuang GB, Li PP, et al
    Marsdenia tenacissima extract restored gefitinib sensitivity in resistant non-small cell lung cancer cells.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  90. STOYANOV E , Uddin M, Mankuta D, Dubinett SM, et al
    Mast cells and histamine enhance the proliferation of non-small cell lung cancer cells.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  91. YANG J , Shen Y, Liu B, Tong Y, et al
    Promoter methylation of BRMS1 correlates with smoking history and poor survival in non-small cell lung cancer patients.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  92. KOZU Y , Tsuta K, Kohno T, Sekine I, et al
    The usefulness of mutation-specific antibodies in detecting epidermal growth factor receptor mutations and in predicting response to tyrosine kinase inhibitor therapy in lung adenocarcinoma.
    Lung Cancer. 2011;73:45-50.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  93. TAO H , Mimura Y, Aoe K, Kobayashi S, et al
    Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  94. PEDDLE-MCINTYRE CJ , Bell G, Fenton D, McCargar L, et al
    Feasibility and preliminary efficacy of progressive resistance exercise training in lung cancer survivors.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  95. PALLIS AG , Scarci M
    Are we treating enough elderly patients with early stage non-small cell lung cancer?
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  96. KATO T , Daigo Y, Aragaki M, Ishikawa K, et al
    Overexpression of KIAA0101 predicts poor prognosis in primary lung cancer patients.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  97. KIM ST , Uhm JE, Lee J, Sun JM, et al
    Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  98. GOTTSCHLING S , Jauch A, Kuner R, Herpel E, et al
    Establishment and comparative characterization of novel squamous cell non-small cell lung cancer cell lines and their corresponding tumor tissue.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  99. GERVAIS R , Hainsworth JD, Blais N, Besse B, et al
    Phase II study of sunitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  100. SHUMWAY D , Corbin K, Salgia R, Hoffman P, et al
    Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  101. PHERNAMBUCQ EC , Palma DA, Vincent A, Smit EF, et al
    Time and dose-related changes in radiological lung density after concurrent chemoradiotherapy for lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  102. KONDO R , Yoshida K, Kawakami S, Shiina T, et al
    Efficacy of CT screening for lung cancer in never-smokers: Analysis of Japanese cases detected using a low-dose CT screen.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  103. KONDO R , Yoshida K, Kawakami S, Shiina T, et al
    Different efficacy of CT screening for lung cancer according to histological type: Analysis of Japanese-smoker cases detected using a low-dose CT screen.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  104. BENZO R , Wigle D, Novotny P, Wetzstein M, et al
    Preoperative pulmonary rehabilitation before lung cancer resection: Results from two randomized studies.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  105. RECK M , Hermes A, Tan EH, Felip E, et al
    Tissue sampling in lung cancer: A review in light of the MERIT experience.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  106. CHEN X , Gorlov IP, Merriman KW, Weng SF, et al
    Association of smoking with tumor size at diagnosis in non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  107. XU Y , Zhang Y, Ma S
    EGFR inhibitors with concurrent thoracic radiation therapy for locally advanced non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  108. ALMASI CE , Christensen IJ, Hoyer-Hansen G, Dano K, et al
    Urokinase receptor forms in serum from non-small cell lung cancer patients: Relation to prognosis.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  109. OLEKSIEWICZ U , Daskoulidou N, Liloglou T, Tasopoulou K, et al
    Neuroglobin and myoglobin in non-small cell lung cancer: Expression, regulation and prognosis.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  110. WU SG , Yang CH, Yu CJ, Lee JH, et al
    Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations.
    Lung Cancer. 2011;72:333-9.
    PubMed     Text format     Related articles    Abstract available



  111. USUDA J , Ichinose S, Ishizumi T, Ohtani K, et al
    Klotho is a novel biomarker for good survival in resected large cell neuroendocrine carcinoma of the lung.
    Lung Cancer. 2011;72:355-9.
    PubMed     Text format     Related articles    Abstract available



  112. ZHENG H , Hu XF, Jiang GN, Gao W, et al
    Define relative incomplete resection by highest mediastinal lymph node metastasis for non-small cell lung cancers: rationale based on prognosis analysis.
    Lung Cancer. 2011;72:348-54.
    PubMed     Text format     Related articles    Abstract available



  113. ANDERSEN S , Eilertsen M, Donnem T, Al-Shibli K, et al
    Diverging prognostic impacts of hypoxic markers according to NSCLC histology.
    Lung Cancer. 2011;72:294-302.
    PubMed     Text format     Related articles    Abstract available



  114. VAN DEN BERG RM , Snijders PJ, Grunberg K, Kooi C, et al
    Comprehensive CADM1 promoter methylation analysis in NSCLC and normal lung specimens.
    Lung Cancer. 2011;72:316-21.
    PubMed     Text format     Related articles    Abstract available



  115. WANG T , Yan XB, Zhao JJ, Ye J, et al
    Gene associated with retinoid-interferon-induced mortality-19 suppresses growth of lung adenocarcinoma tumor in vitro and in vivo.
    Lung Cancer. 2011;72:287-93.
    PubMed     Text format     Related articles    Abstract available



  116. YOSHIDA A , Tsuta K, Watanabe S, Sekine I, et al
    Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component.
    Lung Cancer. 2011;72:309-15.
    PubMed     Text format     Related articles    Abstract available



  117. SHIMOKAWA H , Uramoto H, Onitsuka T, Iwata T, et al
    TS expression predicts postoperative recurrence in adenocarcinoma of the lung.
    Lung Cancer. 2011;72:360-4.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  118. GIOULBASANIS I , Georgoulias P, Vlachostergios PJ, Baracos V, et al
    Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: Interrelations and associations with prognosis.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  119. TONG J , Sun X, Cheng H, Zhao D, et al
    Expression of p16 in non-small cell lung cancer and its prognostic significance: A meta-analysis of published literatures.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  120. PAIK PK , Rudin CM, Pietanza MC, Brown A, et al
    A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  121. PAPADOPOULOS A , Guida F, Cenee S, Cyr D, et al
    Cigarette smoking and lung cancer in women: Results of the French ICARE case-control study.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  122. BOVER I , Rolfo C, Jantus-Lewintre E, Sirera R, et al
    Fifth Educational Symposium of the Spanish Lung Cancer Group: Report on the Molecular Biology Workshop.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  123. HUI L , Qing YL, Qian CZ, Ning LY, et al
    Brain metastasis as the first manifestation of small cell lung cancer in a female adolescent.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  124. WANG R , Zhang J, Chen S, Lu M, et al
    Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  125. GRIDELLI C , Ardizzoni A, Barni S, Crino L, et al
    Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: Results from the Italian observational "SUN" (Survey on the lUng cancer maNagement) study.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  126. BANZ K , Bischoff H, Brunner M, Chouaid C, et al
    Comparison of treatment costs of grade 3/4 adverse events associated with erlotinib or pemetrexed maintenance therapy for patients with advanced non-small-cell lung cancer (NSCLC) in Germany, France, Italy, and Spain.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  127. VERGNENEGRE A , Monnet I, Chouaid C, Hureaux J, et al
    Multicenter observational study of erlotinib therapy (OBSTAR) for non small-cell lung cancer: A GFPC study.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  128. SHUKUYA T , Takahashi T, Naito T, Kaira R, et al
    Continuous EGFR-TKI administration following radiotherapy for non-small cell lung cancer patients with isolated CNS failure.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  129. TSUCHIYA T , Fukuda T, Furuiye M, Kawabuchi K, et al
    Pharmacoeconomic analysis of consolidation therapy with pemetrexed after first-line chemotherapy for non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  130. KU GY , Haaland BA, de Lima Lopes G Jr
    Gefitinib vs. chemotherapy as first-line therapy in advanced non-small cell lung cancer: Meta-analysis of phase III trials.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  131. LIN A , Zhang X, Ruan YY, Wang Q, et al
    HLA-F expression is a prognostic factor in patients with non-small-cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  132. JIANG XD , Dai P, Wu J, Song DA, et al
    Inhibitory effect of radiotherapy combined with weekly recombinant human endostatin on the human pulmonary adenocarcinoma A549 xenografts in nude mice.
    Lung Cancer. 2011;72:165-71.
    PubMed     Text format     Related articles    Abstract available



  133. BANDO K , Haba R, Kushida Y, Kadota K, et al
    Utility of immediate cytologic diagnosis of lung masses using ultrafast Papanicolaou stain.
    Lung Cancer. 2011;72:172-6.
    PubMed     Text format     Related articles    Abstract available



  134. SHIBUYA K , Fujiwara T, Yasufuku K, Alaa M, et al
    In vivo microscopic imaging of the bronchial mucosa using an endo-cytoscopy system.
    Lung Cancer. 2011;72:184-90.
    PubMed     Text format     Related articles    Abstract available



  135. WU JY , Wu SG, Yang CH, Chang YL, et al
    Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations.
    Lung Cancer. 2011;72:205-12.
    PubMed     Text format     Related articles    Abstract available



  136. LEE JH , Jung EJ, Jeon K, Koh WJ, et al
    Treatment outcomes of patients with adenoid cystic carcinoma of the airway.
    Lung Cancer. 2011;72:244-9.
    PubMed     Text format     Related articles    Abstract available



    April 2011
  137. JOERGER M , Dejong D, Burylo A, Burgers JA, et al
    Tubuline, BRCA1, ERCC1, Abraxas, RAP80 mRNA expression, p53/p21 immunohistochemistry and clinical outcome in patients with advanced non small-cell lung cancer receiving first-line platinum-gemcitabine chemotherapy.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles   



  138. MASTERS GA , Wang X, Hodgson L, Shea T, et al
    A phase II trial of high dose carboplatin and paclitaxel with G-CSF and peripheral blood stem cell support followed by surgery and/or chest radiation in patients with stage III non-small cell lung cancer: CALGB 9531.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles   



  139. KUDO K , Ohyanagi F, Horiike A, Miyauchi E, et al
    Clinicopathological findings of non-small-cell lung cancer with high serum progastrin-releasing peptide concentrations.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles   



  140. HATA A , Katakami N, Yoshioka H, Fujita S, et al
    Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: Clinical benefit with optimal patient selection.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles   



  141. HOCKER JR , Peyton MD, Lerner MR, Mitchell SL, et al
    Serum discrimination of early-stage lung cancer patients using electrospray-ionization mass spectrometry.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles   



  142. USUDA J , Ichinose S, Ishizumi T, Ohtani K, et al
    Klotho predicts good clinical outcome in patients with limited-disease small cell lung cancer who received surgery.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles   



  143. RAVIV Y , Shitrit D, Amital A, Fox B, et al
    Lung cancer in lung transplant recipients: Experience of a tertiary hospital and literature review.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles   



  144. THOMSON D , Hulse P, Lorigan P, Faivre-Finn C, et al
    The role of positron emission tomography in management of small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles   



  145. MA H , Shu Y, Pan S, Chen J, et al
    Polymorphisms of key chemokine genes and survival of non-small cell lung cancer in Chinese.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles   



  146. WANG ZM , Lu J, Liu T, Chen KM, et al
    CT-guided interstitial brachytherapy of inoperable non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles   



  147. MAH V , Marquez D, Alavi M, Maresh EL, et al
    Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles   



  148. LOWE M , Molassiotis A
    A longitudinal qualitative analysis of the factors that influence patient distress within the lung cancer population.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles   



  149. RUPPERT AM , Lerolle U, Carette MF, Lavole A, et al
    Coexisting pulmonary nodules in operable lung cancer: Prevalence and probability of malignancy.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles   



  150. LANGE A , Gustke H, Glassmeier G, Heine M, et al
    Neuronal differentiation by indomethacin and IBMX inhibits proliferation of small cell lung cancer cells in vitro.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles   



  151. SHEN M , Cawthon R, Rothman N, Weinstein SJ, et al
    A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  152. FRUH M
    The search for improved systemic therapy of non-small cell lung cancer-What are today's options?
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  153. HOLVOET T , van Meerbeeck JP, Van De Wiele C, Salhi B, et al
    Quantitative Perfusion Scintigraphy or Anatomic Segment Method in lung cancer resection.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  154. WAGNER PL , Stiedl AC, Wilbertz T, Petersen K, et al
    Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinoma.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  155. MELLSTEDT H , Vansteenkiste J, Thatcher N
    Vaccines for the treatment of non-small cell lung cancer: Investigational approaches and clinical experience.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  156. VOS MS , de Haes HJ
    Denial indeed is a process.
    Lung Cancer. 2011;72:138.
    PubMed     Text format     Related articles   



  157. CAMERLINGO R , Franco R, Tirino V, Cantile M, et al
    Establishment and phenotypic characterization of the first human pulmonary blastoma cell line.
    Lung Cancer. 2011;72:23-31.
    PubMed     Text format     Related articles    Abstract available



  158. WINGET M , Fleming J, Li X, Gao Z, et al
    Uptake and tolerance of adjuvant chemotherapy in early stage NSCLC patients in Alberta, Canada.
    Lung Cancer. 2011;72:52-8.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  159. KAWAHARA A , Azuma K, Sumi A, Taira T, et al
    Identification of non-small-cell lung cancer with activating EGFR mutations in malignant effusion and cerebrospinal fluid: Rapid and sensitive detection of exon 19 deletion E746-A750 and exon 21 L858R mutation by immunocytochemistry.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  160. HAN JY , Kim JY, Lee SH, Yoo NJ, et al
    Association between plasma hepatocyte growth factor and gefitinib resistance in patients with advanced non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  161. KNEZ L , Sodja E, Kern I, Kosnik M, et al
    Predictive value of multidrug resistance proteins, topoisomerases II and ERCC1 in small cell lung cancer: A systematic review.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  162. DE MARINIS F , Rossi A, Di Maio M, Ricciardi S, et al
    Treatment of advanced non-small-cell lung cancer: Italian Association of Thoracic Oncology (AIOT) clinical practice guidelines.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  163. HEIGENER DF , Wu YL, van Zandwijk N, Mali P, et al
    Second-line erlotinib in patients with advanced non-small-cell lung cancer: Subgroup analyses from the TRUST study.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  164. WINKLER V , Ng N, Tesfaye F, Becher H, et al
    Predicting lung cancer deaths from smoking prevalence data.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  165. LYONS G , Quadrelli S, Jordan P, Colt H, et al
    Clinical impact of the use of the revised International Association for the Study of Lung Cancer staging system to operable non-small-cell lung cancers.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  166. HORI S , Nishiumi S, Kobayashi K, Shinohara M, et al
    A metabolomic approach to lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  167. HANAGIRI T , Sugaya M, Takenaka M, Oka S, et al
    Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  168. SAKAKIBARA-KONISHI J , Oizumi S, Kinoshita I, Shinagawa N, et al
    Phase I study of concurrent real-time tumor-tracking thoracic radiation therapy with paclitaxel and carboplatin in locally advanced non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  169. LIN HC , Yu CP, Lin HA, Lee HS, et al
    A case of lung cancer metastasized to the gastrointestinal anastomosis site where the primary gastric cancer was resected 17 years ago.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  170. LEIDINGER P , Keller A, Borries A, Huwer H, et al
    Specific peripheral miRNA profiles for distinguishing lung cancer from COPD.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  171. SONG X , Varker H, Eichelbaum M, Stopfer P, et al
    Treatment of lung cancer patients and concomitant use of drugs interacting with cytochrome P450 isoenzymes.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  172. BOTREL TE , Clark O, Clark L, Paladini L, et al
    Efficacy of bevacizumab (Bev) plus chemotherapy (CT) compared to CT alone in previously untreated locally advanced or metastatic non-small cell lung cancer (NSCLC): Systematic review and meta-analysis.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  173. TOGASHI Y , Masago K, Fujita S, Hatachi Y, et al
    Differences in adverse events between 250mg daily gefitinib and 150mg daily erlotinib in Japanese patients with non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  174. KATO T , Daigo Y, Aragaki M, Ishikawa K, et al
    Overexpression of MAD2 predicts clinical outcome in primary lung cancer patients.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  175. BENNOUNA J , Senellart H, Hiret S, Vaissiere N, et al
    Impact of histology on survival of resected non-small cell lung cancer (NSCLC) receiving adjuvant chemotherapy: Subgroup analysis of the adjuvant vinorelbine (NVB) cisplatin (CDDP) versus observation in the ANITA trial.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  176. SIEREN JC , Smith AR, Thiesse J, Namati E, et al
    Exploration of the volumetric composition of human lung cancer nodules in correlated histopathology and computed tomography.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  177. FAN YG , Jiang Y, Chang RS, Yao SX, et al
    Prior lung disease and lung cancer risk in an occupational-based cohort in Yunnan, China.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  178. CHEN CY , Chang YL, Shih JY, Lin JW, et al
    Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  179. REKA AK , Goswami MT, Krishnapuram R, Standiford TJ, et al
    Molecular cross-regulation between PPAR-gamma and other signaling pathways: Implications for lung cancer therapy.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  180. SHEIKH H , Colaco R, Lorigan P, Blackhall F, et al
    Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trial.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  181. CARDENAL F , Arnaiz MD, Moran T, Jove J, et al
    Phase I study of concurrent chemoradiation with pemetrexed and cisplatin followed by consolidation pemetrexed for patients with unresectable stage III non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  182. SHIROYAMA T , Komuta K, Imamura F, Hirashima T, et al
    Phase II study of S-1 monotherapy in platinum-refractory, advanced non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  183. HUBNER RA , Goldstein R, Mitchell S, Jones A, et al
    Influence of co-morbidity on renal function assessment by Cockcroft-Gault calculation in lung cancer and mesothelioma patients receiving platinum-based chemotherapy.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  184. NOGAMI N , Hotta K, Kuyama S, Kiura K, et al
    A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  185. OUMERACI T , Schmidt B, Wolf T, Zapatka M, et al
    Bronchoalveolar lavage fluid of lung cancer patients: Mapping the uncharted waters using proteomics technology.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  186. SOERJOMATARAM I , Barendregt JJ, Gartner C, Kunst A, et al
    Reducing inequalities in lung cancer incidence through smoking policies.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  187. AKCA H , Demiray A, Tokgun O, Yokota J, et al
    Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K/AKT/NFkB pathway in lung cancer cells.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  188. ZHAO M , Gao FH, Wang JY, Liu F, et al
    JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  189. LIANG YH , Kuo SW, Lin YL, Chang YL, et al
    Disseminated microvascular pulmonary tumor embolism from non-small cell lung cancer leading to pulmonary hypertension followed by sudden cardiac arrest.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  190. HESTBECH MS , Siersma V, Dirksen A, Pedersen JH, et al
    Participation bias in a randomised trial of screening for lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  191. DEMURA M , Demura Y, Ameshima S, Ishizaki T, et al
    Changes in aromatase (CYP19) gene promoter usage in non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  192. GRANGER CL , McDonald CF, Berney S, Chao C, et al
    Exercise intervention to improve exercise capacity and health related quality of life for patients with Non-small cell lung cancer: A systematic review.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  193. PIAO JM , Kim HN, Song HR, Kweon SS, et al
    p53 codon 72 polymorphism and the risk of lung cancer in a Korean population.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  194. SAHOO R , V VH, Babu VC, V Patil Okaly G, et al
    Screening for EGFR mutations in lung cancer, a report from India.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  195. CALIFANO R , Griffiths R, Lorigan P, Ashcroft L, et al
    Randomised phase II trial of 4 dose levels of single agent docetaxel in performance status (PS) 2 patients with advanced non-small cell lung cancer (NSCLC): DOC PS2 trial. Manchester lung cancer group.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  196. LEE YL , Kuo WH, Lin CW, Chen W, et al
    Association of genetic polymorphisms of CXCL12/SDF1 gene and its receptor, CXCR4, to the susceptibility and prognosis of non-small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  197. CUI D , Wang Z, Zhao E, Ma J, et al
    NAT2 polymorphism and lung cancer risk: A meta-analysis.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  198. ZHU D , Ma T, Niu Z, Zheng J, et al
    Prognostic significance of metabolic parameters measured by (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



    January 2011
  199. MULSHINE JL , van Klaveren RJ
    Lung cancer screening: What is the benefit and what do we do about it?
    Lung Cancer. 2011.
    PubMed     Text format     Related articles   



  200. HIROSE T , Nakashima M, Shirai T, Kusumoto S, et al
    Phase II trial of amrubicin and carboplatin in patients with sensitive or refractory relapsed small-cell lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  201. SCHUURBIERS OC , Tournoy KG, Schoppers HJ, Dijkman BG, et al
    EUS-FNA for the detection of left adrenal metastasis in patients with lung cancer.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  202. LEE YJ , Kim JH, Kim SK, Ha SJ, et al
    Lung cancer in never smokers: Change of a mindset in the molecular era.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  203. CHANG CC , Chi KH, Kao SJ, Hsu PS, et al
    Upfront gefitinib/erlotinib treatment followed by concomitant radiotherapy for advanced lung cancer: A mono-institutional experience.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  204. CHEN W , Gao X, Tian Q, Chen L, et al
    A comparison of autofluorescence bronchoscopy and white light bronchoscopy in detection of lung cancer and preneoplastic lesions: A meta-analysis.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  205. GRIDELLI C , De Marinis F, Di Maio M, Cortinovis D, et al
    Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating Epidermal Growth Factor Receptor mutation: Implications for clinical practice and open issues.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  206. GRIDELLI C , De Marinis F, Di Maio M, Cortinovis D, et al
    Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidence.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  207. ASANO M , Fujimoto N, Gemba K, Wada S, et al
    Acute onset of brain atrophy and dementia in a patient with small cell lung cancer: A case report.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  208. LIU S , Wang D, Chen B, Wang Y, et al
    The safety and efficacy of EGFR TKIs monotherapy versus single-agent chemotherapy using third-generation cytotoxics as the first-line treatment for patients with advanced non-small cell lung cancer and poor performance status.
    Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  209. JIN G , Jeon HS, Yang E, Park JY, et al
    Mutation analysis of the FRK gene in non-small cell lung cancers.
    Lung Cancer. 2011;71:115-7.
    PubMed     Text format     Related articles   



  210. CHANG A
    Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC.
    Lung Cancer. 2011;71:3-10.
    PubMed     Text format     Related articles    Abstract available



  211. KUROTANI R , Kumaki N, Naizhen X, Ward JM, et al
    Secretoglobin 3A2/uteroglobin-related protein 1 is a novel marker for pulmonary carcinoma in mice and humans.
    Lung Cancer. 2011;71:42-8.
    PubMed     Text format     Related articles    Abstract available



  212. TSUTA K , Raso MG, Kalhor N, Liu DD, et al
    Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lung.
    Lung Cancer. 2011;71:34-41.
    PubMed     Text format     Related articles    Abstract available



  213. KIM DW , Lee SH, Lee JS, Lee MA, et al
    A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinoma harboring EGFR mutations.
    Lung Cancer. 2011;71:65-9.
    PubMed     Text format     Related articles    Abstract available



  214. SIWICKY MD , Petrik JJ, Moorehead RA
    The function of IGF-IR in NNK-mediated lung tumorigenesis.
    Lung Cancer. 2011;71:11-8.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  215. QIAN B , Zhang H, Zhang L, Zhou X, et al
    Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  216. SPILIOTAKI M , Markomanolaki H, Mela M, Mavroudis D, et al
    Targeting the insulin-like growth factor I receptor inhibits proliferation and VEGF production of non-small cell lung cancer cells and enhances paclitaxel-mediated anti-tumor effect.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  217. LIU X , Liang M, Wang Y, Chen K, et al
    The outcome differences of CT screening for lung cancer pre and post following an algorithm in Zhuhai, China.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  218. KOO HK , Jin SM, Lee CH, Lim HJ, et al
    Factors associated with recurrence in patients with curatively resected stage I-II lung cancer.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  219. HENSCHKE CI , Boffetta P, Gorlova O, Yip R, et al
    Assessment of lung-cancer mortality reduction from CT Screening.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  220. JUNG EJ , Lee JH, Jeon K, Koh WJ, et al
    Treatment outcomes for patients with synchronous multiple primary non-small cell lung cancer.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  221. MA H , Chen J, Pan S, Dai J, et al
    Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  222. BANNA GL , Di Maio M, Follador A, Collova E, et al
    Italian Survey on Adjuvant treatment of non-small cell lung cancer (ISA).
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  223. BREVET M , Johnson ML, Azzoli CG, Ladanyi M, et al
    Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  224. LIU L , Yuan P, Wu C, Zhang X, et al
    Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  225. CHO S , Kim MJ, Choi YY, Yoo SS, et al
    Associations between polymorphisms in DNA repair genes and TP53 mutations in non-small cell lung cancer.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  226. SAKAI Y , Ohbayashi C, Kanomata N, Kajimoto K, et al
    Significance of microscopic invasion into hilar peribronchovascular soft tissue in resection specimens of primary non-small cell lung cancer.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    November 2010
  227. FOWKE JH , Gao YT, Chow WH, Cai Q, et al
    Urinary isothiocyanate levels and lung cancer risk among non-smoking women: A prospective investigation.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  228. LESTUZZI C , Bearz A, Lafaras C, Gralec R, et al
    Neoplastic pericardial disease in lung cancer: Impact on outcomes of different treatment strategies. A multicenter study.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  229. VOULGARIS E , Pentheroudakis G, Pappa L, Bafa M, et al
    Positive urinary cytology in patients with lung cancer in the absence of obvious urine tract metastases.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  230. TAKEDA M , Okamoto I, Hirabayashi N, Kitano M, et al
    Thymidylate synthase and dihydropyrimidine dehydrogenase expression levels are associated with response to S-1 plus carboplatin in advanced non-small cell lung cancer.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  231. ZIETEMANN V , Duell T
    Prevalence and effectiveness of first-, second-, and third-line systemic therapy in a cohort of unselected patients with advanced non-small cell lung cancer.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  232. CHEN Y , Cui T, Knosel T, Yang L, et al
    IGFBP7 is a p53 target gene inactivated in human lung cancer by DNA hypermethylation.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  233. GROSS BH , Brown RK, Kalemkerian GP
    Optimal anatomic coverage for CT in staging lung cancer: Lessons from PET-CT correlation.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  234. LO YL , Hsiao CF, Jou YS, Chang GC, et al
    Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  235. LEE HY , Lee KS, Ahn MJ, Hwang HS, et al
    New CT response criteria in non-small cell lung cancer: Proposal and application in EGFR tyrosine kinase inhibitor therapy.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  236. YIN M , Yan J, Voutsina A, Tibaldi C, et al
    No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: A meta-analysis.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  237. WU D , Erwin D, Rosner GL
    Sojourn time and lead time projection in lung cancer screening.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  238. CAMPS C , Jantus-Lewintre E, Cabrera A, Blasco A, et al
    The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patients.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  239. XU Y , Ma S, Ji Y, Sun X, et al
    Concomitant chemoradiotherapy using pemetrexed and carboplatin for unresectable stage III non-small cell lung cancer (NSCLC): Preliminary results of a phase II study.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    October 2010
  240. ALAA RM M , Shibuya K, Fujiwara T, Wada H, et al
    Risk of lung cancer in patients with preinvasive bronchial lesions followed by autofluorescence bronchoscopy and chest computed tomography.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  241. GARASSINO MC , Torri V, Michetti G, Lo Dico M, et al
    Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: A multi-institutional retrospective analysis.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  242. KAPTEIN AA , Yamaoka K, Snoei L, Kobayashi K, et al
    Illness perceptions and quality of life in Japanese and Dutch patients with non-small-cell lung cancer.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  243. HAN B , Gao G, Wu W, Gao Z, et al
    Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  244. ROSSMAN J , Reddy V, Cantor A, Miley D, et al
    Phase II study of dose-intense chemotherapy with sequential topoisomerase-targeting regimens with irinotecan/oxaliplatin followed by etoposide/carboplatin in chemotherapy naive patients with extensive small cell lung cancer.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  245. SMITH CB , Bonomi M, Packer S, Wisnivesky JP, et al
    Disparities in lung cancer stage, treatment and survival among American Indians and Alaskan Natives.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  246. BERTINO EM , Otterson GA
    Benefits and limitations of antiangiogenic agents in patients with non-small cell lung cancer.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  247. SUZAWA N , Ito M, Qiao S, Uchida K, et al
    Assessment of factors influencing FDG uptake in non-small cell lung cancer on PET/CT by investigating histological differences in expression of glucose transporters 1 and 3 and tumour size.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  248. KANG DY , Yoon YS, Kim HK, Choi YS, et al
    Primary salivary gland-type lung cancer: Surgical outcomes.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  249. KIKUCHI J , Kinoshita I, Shimizu Y, Kikuchi E, et al
    Minichromosome maintenance (MCM) protein 4 as a marker for proliferation and its clinical and clinicopathological significance in non-small cell lung cancer.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  250. JONES LW , Eves ND, Spasojevic I, Wang F, et al
    Effects of Aerobic Training on Oxidative Status in Postsurgical Non-Small Cell Lung Cancer Patients: A Pilot Study.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  251. VANNESTE BG , Haas RL, Bard MP, Rijna H, et al
    Involved field radiotherapy for locally advanced non-small cell lung cancer: Isolated mediastinal nodal relapse.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  252. BOELENS MC , Gustafson AM, Postma DS, Kok K, et al
    A chronic obstructive pulmonary disease related signature in squamous cell lung cancer.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  253. GRANGER C , Denehy L
    Exercise interventions following surgery for non-small cell lung cancer (NSCLC): The need for future randomised controlled trials.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles   



  254. RHEE CK , Lee SH, Kim JS, Kim SJ, et al
    A multicenter phase II study of belotecan, a new camptothecin analogue, as a second-line therapy in patients with small cell lung cancer.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  255. HATA A , Katakami N, Fujita S, Kaji R, et al
    Amrubicin at a lower-dose with routine prophylactic use of granulocyte-colony stimulating factor for relapsed small-cell lung cancer.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  256. OKAMOTO I , Takahashi T, Okamoto H, Nakagawa K, et al
    Single-agent gefitinib with concurrent radiotherapy for locally advanced non-small cell lung cancer harboring mutations of the epidermal growth factor receptor.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  257. ILEANA E , Greillier L, Moutardier V, Barlesi F, et al
    Surgical resection of liver non-small cell lung cancer metastasis: A dual weapon?
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  258. PARK S , Ha SY, Cho HY, Chung DH, et al
    Prognostic implications of hypoxia-inducible factor-1alpha in epidermal growth factor receptor-negative non-small cell lung cancer.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  259. CHEUNG WY , Butler JR, Kliewer EV, Demers AA, et al
    Analysis of Wait Times and Costs During the Peri-Diagnostic Period for Non-Small Cell Lung Cancer.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  260. KU GY , Chopra A, Lopes GD Jr
    Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced hepatotoxicity.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  261. MYERSON JS , Faria A, Puglisi M, Starling N, et al
    The value of day 8 blood count in treatment decisions when using oral vinorelbine in non-small cell lung cancer.
    Lung Cancer. 2010;69:365-6.
    PubMed     Text format     Related articles   



  262. LAACK E , Sauter G, Bokemeyer C
    Lessons learnt from gefitinib and erlotinib: Key insights into small-molecule EGFR-targeted kinase inhibitors in non-small cell lung cancer.
    Lung Cancer. 2010;69:259-264.
    PubMed     Text format     Related articles    Abstract available



  263. BLINMAN P , McLachlan SA, Nowak AK, Duric VM, et al
    Lung cancer clinicians' preferences for adjuvant chemotherapy in non-small-cell lung cancer: What makes it worthwhile?
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  264. MURAKAMI S , Yokose T, Saito H, Sakuma Y, et al
    Recurrent EML4-ALK-associated lung adenocarcinoma with a slow clinical course.
    Lung Cancer. 2010;69:361-4.
    PubMed     Text format     Related articles    Abstract available



  265. GALVAN JA , Gonzalez MV, Crespo G, Folgueras MV, et al
    Snail nuclear expression parallels higher malignancy potential in neuroendocrine lung tumors.
    Lung Cancer. 2010;69:289-95.
    PubMed     Text format     Related articles    Abstract available



  266. CHEN X , Wan J, Liu J, Xie W, et al
    Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients.
    Lung Cancer. 2010;69:348-54.
    PubMed     Text format     Related articles    Abstract available



  267. JIN G , Kim MJ, Jeon HS, Choi JE, et al
    PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers.
    Lung Cancer. 2010;69:279-83.
    PubMed     Text format     Related articles    Abstract available



    August 2010
  268. YASUDA H , Soejima K, Nakayama S, Kawada I, et al
    Bronchoscopic Microsampling is a Useful Complementary Diagnostic Tool for Detecting Lung Cancer.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  269. SMITH SL , Palma D, Parhar T, Alexander CS, et al
    Inoperable early stage non-small cell lung cancer: Comorbidity, patterns of care and survival.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  270. WANG XC , Du LQ, Tian LL, Wu HL, et al
    Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  271. GALETTA D , Gebbia V, Silvestris N, Ferrau F, et al
    Cisplatin, fotemustine and whole-brain radiotherapy in non-small cell lung cancer patients with asymptomatic brain metastases: A multicenter phase II study of the Gruppo Oncologico Italia Meridionale (GOIM 2603).
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  272. GIRONES R , Torregrosa D, Gomez-Codina J, Maestu I, et al
    Prognostic impact of comorbidity in elderly lung cancer patients: Use and comparison of two scores.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  273. ROTHSCHILD SI , Kappeler A, Ratschiller D, Betticher DC, et al
    The stem cell gene "inhibitor of differentiation 1" (ID1) is frequently expressed in non-small cell lung cancer.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  274. SALAZAR F , Molina MA, Sanchez-Ronco M, Moran T, et al
    First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  275. VOS MS , Putter H, van Houwelingen HC, de Haes HC, et al
    Denial and social and emotional outcomes in lung cancer patients: The protective effect of denial.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  276. BERNARD M , Brignone M, Adehossi A, Pefoura S, et al
    Perception of alopecia by patients requiring chemotherapy for non-small-cell lung cancer: A willingness to pay study.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  277. RICH AL , Tata LJ, Stanley RA, Free CM, et al
    Lung cancer in England: Information from the National Lung Cancer Audit (LUCADA).
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  278. NUIJTEN M , Heigener DF, Bischoff HG, Chouaid C, et al
    Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer.
    Lung Cancer. 2010;69 Suppl 1:S4-10.
    PubMed     Text format     Related articles    Abstract available



  279. STANISIC S , Bischoff HG, Heigener DF, Vergnenegre A, et al
    Societal cost savings through bevacizumab-based treatment in non-small cell lung cancer (NSCLC).
    Lung Cancer. 2010;69 Suppl 1:S24-30.
    PubMed     Text format     Related articles    Abstract available



  280. MUELLER E
    Editorial: Comparative efficacy and cost associated with new agents in the treatment of non-small cell lung cancer (NSCLC).
    Lung Cancer. 2010;69 Suppl 1:S1-3.
    PubMed     Text format     Related articles   



  281. BISCHOFF HG , Heigener DF, Walzer S, Nuijten M, et al
    Costs of bevacizumab and pemetrexed for advanced non-squamous NSCLC in Italy and Germany.
    Lung Cancer. 2010;69 Suppl 1:S18-23.
    PubMed     Text format     Related articles    Abstract available



  282. GIULIANI G , Grossi F, de Marinis F, Walzer S, et al
    Cost-effectiveness analysis of bevacizumab versus pemetrexed for advanced non-squamous NSCLC in Italy.
    Lung Cancer. 2010;69 Suppl 1:S11-7.
    PubMed     Text format     Related articles    Abstract available



    July 2010
  283. CHOUGULE M , Patel AR, Sachdeva P, Jackson T, et al
    Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  284. REINFUSS M , Mucha-Malecka A, Walasek T, Blecharz P, et al
    Palliative thoracic radiotherapy in non-small cell lung cancer. An analysis of 1250 patients. Palliation of symptoms, tolerance and toxicity.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  285. PAULUS JK , Zhou W, Kraft P, Johnson BE, et al
    Haplotypes of estrogen receptor-beta and risk of non-small cell lung cancer in women.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  286. MIN JH , Lee HY, Lee KS, Han J, et al
    Stepwise evolution from a focal pure pulmonary ground-glass opacity nodule into an invasive lung adenocarcinoma: an observation for more than 10 years.
    Lung Cancer. 2010;69:123-6.
    PubMed     Text format     Related articles    Abstract available



  287. GOLLARD R , Jhatakia S, Elliott M, Kosty M, et al
    Large cell/neuroendocrine carcinoma.
    Lung Cancer. 2010;69:13-8.
    PubMed     Text format     Related articles    Abstract available



  288. TROVO M , Linda A, El Naqa I, Javidan-Nejad C, et al
    Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT).
    Lung Cancer. 2010;69:77-85.
    PubMed     Text format     Related articles    Abstract available



  289. AL-WADEI HA , Al-Wadei MH, Masi T, Schuller HM, et al
    Chronic exposure to estrogen and the tobacco carcinogen NNK cooperatively modulates nicotinic receptors in small airway epithelial cells.
    Lung Cancer. 2010;69:33-9.
    PubMed     Text format     Related articles    Abstract available



  290. NAGASHIO R , Sato Y, Matsumoto T, Kageyama T, et al
    Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas.
    Lung Cancer. 2010;69:54-9.
    PubMed     Text format     Related articles    Abstract available



    June 2010
  291. TAKUWA T , Tanaka F, Yoneda K, Torii I, et al
    Diagnosis of synchronous primary lung adenocarcinomas based on epidermal growth factor (EGFR) gene status: A case report.
    Lung Cancer. 2010;68:498-500.
    PubMed     Text format     Related articles    Abstract available



  292. WU PF , Kuo KT, Kuo LT, Lin YT, et al
    O(6)-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers.
    Lung Cancer. 2010;68:484-90.
    PubMed     Text format     Related articles    Abstract available



  293. ZHANG L , Yankelevitz DF, Henschke CI, Reeves AP, et al
    Variation in vascular distribution in small lung cancers.
    Lung Cancer. 2010;68:389-93.
    PubMed     Text format     Related articles    Abstract available



  294. MINAMIYA Y , Saito H, Takahashi N, Ito M, et al
    Expression of the chemokine receptor CXCR4 correlates with a favorable prognosis in patients with adenocarcinoma of the lung.
    Lung Cancer. 2010;68:466-71.
    PubMed     Text format     Related articles    Abstract available



  295. LEE HJ , Xu X, Choe G, Chung DH, et al
    Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study.
    Lung Cancer. 2010;68:375-82.
    PubMed     Text format     Related articles    Abstract available



    May 2010
  296. HORVATH I
    Smells like cancer.
    Lung Cancer. 2010;68:127-8.
    PubMed     Text format     Related articles   



  297. CARPAGNANO GE , Palladino GP, Gramiccioni C, Foschino Barbaro MP, et al
    Exhaled ERCC-1 and ERCC-2 microsatellite alterations in NSCLC patients.
    Lung Cancer. 2010;68:305-7.
    PubMed     Text format     Related articles    Abstract available



    April 2010
  298. STAHEL R , Baas P, Faivre-Finn C, Dooms C, et al
    Meeting report: 2nd meeting of the European Thoracic Oncology Platform (ETOP).
    Lung Cancer. 2010;68:121-4.
    PubMed     Text format     Related articles   



  299. BASTIDE K , Ugolin N, Levalois C, Bernaudin JF, et al
    Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level?
    Lung Cancer. 2010;68:1-9.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: